20
Views
4
CrossRef citations to date
0
Altmetric
Article

Cerebrospinal fluid neuron‐specific enolase in non‐selected patients

, &
Pages 553-558 | Received 04 Aug 2003, Accepted 01 Apr 2004, Published online: 08 Jul 2009

References

  • Palmio J, Peltola J, Vuorinen P, Laine S, Suhonen J, Keranen T. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures. J Neurol Sci 2001; 183: 27–31.
  • Rodriguez-Nunez A, Cid E, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, Castro-Gago M. Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentra-tions in cerebrospinal fluid of children with meningitis. Brain Dev 2003; 25: 102–6.
  • Schreiber SS, Sun N, Tocco G, Baudry M, DeGiorgio CM. Expression of neuron-specific enolase in adult rat brain following status epilepticus. Exp Neurol 1999; 159: 329–31.
  • Steinhoff BJ, Tumani H, Otto M, Mursch K, Wiltfang J, Herrendorf G, Bittermann HJ, Felgenhauer K, Paulus W. Markakis E. Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy. Epilepsy Res 1999; 36: 75–82.
  • Tanabe T, Suzuki S, Hara K, Shimakawa S, Wakamiya E, Tamai H. Cerebrospinal fluid and serum neuron-specific enolase levels after febrile seizures. Epilepsia 2001; 42: 504–7.
  • Wong M, Ess K, Landt M. Cerebrospinal fluid neuron-specific enolase following seizures in chil-dren: role of etiology. J Child Neurol 2002; 17: 261–4.
  • Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM. Neuron-specific enolase and S 100B in cerebrosp-inal fluid after severe traumatic brain injury in infants and children. Pediatrics 2002; 109: E31.
  • Rabinowicz AL, Correale JD, Couldwell WT, DeGiorgio CM. CSF neuron-specific enolase after methohexital activation during electrocorticogra-phy. Neurology 1994; 44: 1167–9.
  • Elimian A, Figueroa R, Patel K, Visintainer P, Sehgal PB, Tejani N. Reference values of amniotic fluid neuron-specific enolase. J Matern Fetal Med 2001; 10: 155–8.
  • Nygaard O, Langbakk B, Romner B. Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder. Scand J Clin Lab Invest 1998; 58: 183–6.
  • Blennow M, Savman K, Ilves P, Thoresen M, Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated new-born infants. Acta Paediatr 2001; 90: 1171–5.
  • Correale J, Rabinowicz AL, Heck CN, Smith TD, Loskota WJ, DeGiorgio CM. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier. Neurology 1998; 50: 1388— 91.
  • Ezgu FS, Atalay Y, Gucuyener K, Tunc S, Koc E, Ergenekon E, Tiras U. Neuron-specific enolase levels and neuroimaging in asphyxiated term newborns. J Child Neurol 2002; 17: 824–9.
  • Thornberg E, Thiringer K, Hagberg H, Kjellmer I. Neuron-specific enolase in asphyxiated newborns: association with encephalopathy and cerebral function monitor trace. Arch Dis Child Fetal Neonatal Ed 1995; 72: F39–42.
  • Studahl M, Rosengren L, Gunther G. Hagberg L. Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encepha-litis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol 2000; 247: 636–42.
  • Chekhonin VP, Zhirkov YA, Belyaeva IA, Ryabukhin IA, Gurina OI, Dmitriyeva TB. Serum time course of two brain-specific proteins, alpha(1) brain globulin and neuron-specific eno-lase, in tick-borne encephalitis and Lyme disease. Clin Chim Acta 2002; 320: 117–25.
  • Aksamit AJ Jr, Preissner CM, Homburger HA. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease. Neurology 2001; 57: 728–30.
  • Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, Ironside JW, Will RG, Knight RS. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 70: 744–8.
  • Kohira I, Tsuji T, Ishizu H, Takao Y, Wake A, Abe K, Kuroda S. Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease. Acta Neurol Scand 2000; 102: 385–7.
  • Beems T, Simons KS, Van Geel WJ, De Reus HP, Vos PE, Verbeek MM. Serum- and CSF-concentrations of brain specific proteins in hydro-cephalus. Acta Neurochir (Wien) 2003; 145: 37–43.
  • Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe trau-matic brain injury. J Neurotrauma 2001; 18: 491–8.
  • Osterlundh G, Bjure J, Lannering B, Kjellmer I, Uvebrant P, Marky I. Regional cerebral blood flow and neuron-specific enolase in cerebrospinal fluid in children with acute lymphoblastic leuke-mia during induction treatment. J Pediatr Hematol Oncol 1999; 21: 378–83.
  • Beaudry P, Cohen P, Brandel JP, Delasnerie-Laupretre N, Richard S, Launay JM, Laplanche JL. 14-3-3 protein, neuron-specific enolase, and 5-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 1999; 10: 40–6.
  • Orlino EN Jr, Olmstead CE, Lazareff JA, Peacock WJ, Fisher RS, Fluharty AL. An enzyme immuno-assay for neuron-specific enolase in cerebrospinal fluid. Biochem Mol Med 1997; 61: 41–6.
  • Schmitt B, Bauersfeld U, Schmid ER, Tuchschmid P, Molinari L, Fanconi S, Bandtlow C. Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? Brain Dev 1998; 20: 536 — 9.
  • Nagamatsu M, Mokuno K, Sugimura K, Kiyosawa K, Aoki S, Takahashi A, Kato K. Cerebrospinal fluid levels of S-100b protein and neuron-specific enolase in chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scand 1995; 91: 483–7.
  • Johnsson P, Blomquist S, Luhrs C, Malmkvist G, Alling C, Solem JO. Stahl E. Neuron-specific enolase increases in plasma during and immedi-ately after extracorporeal circulation. Ann Thorac Surg 2000; 69: 750–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.